SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fossati R, Confalonieri C, Torri V, et al.: Cytotoxic and hormonal treatment for metastatic breast cancer: A systemic review of published randomized trials involving 31,510 women. J Clin Oncol 1998; 16: 34393460.
  • 2
    Insa A, Lluch A, Prosper F, et al.: Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: Analysis of 439 patients. Breast Cancer Res Treat 1999; 56: 6778.
  • 3
    Zinser JW, Hortobagyi GN, Buzdar AU, et al.: Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987; 5: 773782.
  • 4
    Schneebaum S, Walker M, Young D, et al.: The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994; 55: 2632.
  • 5
    Pickren JW, Tsukada Y, Lane WW: Liver metastasis: Analysis of autopsy data. In: WeissL, GilbertP, editors. Liver metastasis. Boston: GK Hall Medical; 1982. pp. 219.
  • 6
    Lee YT: Breast carcinoma: Pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol 1984; 7: 443449.
  • 7
    Huber C, Niederwieser D, Schonitzer D, et al.: Liver transplantation followed by high-dose cyclophosphamide, total-body irradiation, and autologous bone marrow transplantation for treatment of metastatic breast cancer. A case report. Transplantation 1984; 37: 311312.
  • 8
    Klijn JG, Berns PM, Bontenbal M, et al.: Clinical breast cancer, new developments in selection and endocrine treatment of patients. J Steroid Biochem Mol Biol 1992; 43: 211221.
  • 9
    Samaan NA, Buzdar AU, Aldinger KA, et al.: Estrogen receptor: A prognostic factor in breast cancer. Cancer 1981; 47: 554560.
  • 10
    Singletary SE, Walsh G, Vauthey JN, et al.: A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003; 8: 241251.
  • 11
    Raab R, Nussbaum KT, Behrend M, et al.: Liver metastases of breast cancer: Results of liver resection. Anticancer Res 1998; 18: 22312233.
  • 12
    Yoshimoto M, Tada T, Saito M, et al.: Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59: 177184.
  • 13
    Elias D, Maisonnette F, Druet-Cabanac M, et al.: An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003; 185: 158164.
  • 14
    Sakamoto Y, Yamamoto J, Yoshimoto M, et al.: Hepatic resection for metastatic breast cancer: Prognostic analysis of 34 patients. World J Surg 2005; 29: 524527.
  • 15
    Adam R, Aloia T, Krissat J, et al.: Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006; 244: 897908.
  • 16
    Wiley J and Sons. UICC. TNM classification of malignant tumors. 6th edition. New York: Springer; 2002.
  • 17
    Simmonds PC, Primrose JN, Colquitt JL, et al.: Surgical resection of hepatic metastases from colorectal cancer: A systemic review of published studies. Br J Cancer 2006; 94: 982999.
  • 18
    Jonas S, Thelen A, Benckert C, et al.: Extented resections of liver metastases from colorectal cancer. World J Surg 2007; 31: 511521.
  • 19
    O'Reilly SM, Richards MA, Rubens RD: Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 1990; 26: 574577.
  • 20
    Wyld L, Gutteridge E, Pinder SE, et al.: Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003; 89: 284290.
  • 21
    Lee YT: Breast carcinoma: Pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol 1984; 7: 443449.
  • 22
    von Minckwitz G, for The Breast Commission of the German Gynaecological Oncology Working Group (AGO): Evidence-based treatment of metastatic breast cancer—2006 recommendations by the AGO Breast Commission. Eur J Cancer 2006; 42: 28972908.
  • 23
    Carlson R: Breast cancer: Practice guidelines in oncology. Vol. 2, 2006. National Comprehensive Cancer Network; 2005.
  • 24
    Pocard M, Pouillart P, Asselain B, et al.: Hepatic resection in metastatic breast cancer: Results and prognostic factors. Eur J Surg Oncol 2000; 26: 155159.
  • 25
    Jonas S, Bechstein WO, Steinmuller T, et al.: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 10801086.
  • 26
    Martinez SR, Young SE, Giuliano AE, et al.: The utility of estrogen receptor, progesteron receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 2006; 191: 281283.